TY - JOUR
T1 - The hallmarks of aging
AU - López-Otín, Carlos
AU - Blasco, Maria A.
AU - Partridge, Linda
AU - Serrano, Manuel
AU - Kroemer, Guido
N1 - Funding Information:
We thank all members of our labs for their helpful comments on the manuscript and apologize for omission of relevant works due to space constraints. C.L.-O. is supported by grants from Ministerio de Economía y Competitividad (MINECO) and Instituto de Salud Carlos III (RTICC) and is an Investigator of the Botín Foundation. M.S. is funded by grants from the MINECO, European Union (ERC Advanced Grant), Regional Government of Madrid, Botín Foundation, Ramón Areces Foundation, and AXA Foundation. L.P. is supported by the Max Planck Society, the ERC, and the Wellcome Trust (UK). M.A.B. is funded by ERC Project TEL STEM CELL; FP7 Projects MARK-AGE; and EuroBATS, MINECO, Regional Government of Madrid, AXA Research Fund, Botín Foundation, and Fundación Lilly (Spain). G.K. is supported by the Ligue Nationale contre le Cancer (Equipes labellisée), Agence Nationale pour la Recherche, AXA Foundation Chair for Longevity Research, European Commission (ERC Advanced Grant, ArtForce, ChemoRes), Fondation pour la Recherche Médicale (FRM), Institut National du Cancer (INCa), Fondation de France, Cancéropôle Ile-de-France, Fondation Bettencourt-Schueller, the LabEx Immuno-Oncology, and the Paris Alliance of Cancer Research Institutes. All of the authors contributed equally to conceive and elaborate upon the ideas presented in this Review. All of the authors can be contacted for discussions or clarifications.
PY - 2013/6/6
Y1 - 2013/6/6
N2 - Aging is characterized by a progressive loss of physiological integrity, leading to impaired function and increased vulnerability to death. This deterioration is the primary risk factor for major human pathologies, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. Aging research has experienced an unprecedented advance over recent years, particularly with the discovery that the rate of aging is controlled, at least to some extent, by genetic pathways and biochemical processes conserved in evolution. This Review enumerates nine tentative hallmarks that represent common denominators of aging in different organisms, with special emphasis on mammalian aging. These hallmarks are: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. A major challenge is to dissect the interconnectedness between the candidate hallmarks and their relative contributions to aging, with the final goal of identifying pharmaceutical targets to improve human health during aging, with minimal side effects.
AB - Aging is characterized by a progressive loss of physiological integrity, leading to impaired function and increased vulnerability to death. This deterioration is the primary risk factor for major human pathologies, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. Aging research has experienced an unprecedented advance over recent years, particularly with the discovery that the rate of aging is controlled, at least to some extent, by genetic pathways and biochemical processes conserved in evolution. This Review enumerates nine tentative hallmarks that represent common denominators of aging in different organisms, with special emphasis on mammalian aging. These hallmarks are: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. A major challenge is to dissect the interconnectedness between the candidate hallmarks and their relative contributions to aging, with the final goal of identifying pharmaceutical targets to improve human health during aging, with minimal side effects.
UR - http://www.scopus.com/inward/record.url?scp=84878864199&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2013.05.039
DO - 10.1016/j.cell.2013.05.039
M3 - Review article
C2 - 23746838
AN - SCOPUS:84878864199
SN - 0092-8674
VL - 153
SP - 1194
JO - Cell
JF - Cell
IS - 6
ER -